[en] Shc homology 2-containing inositol 5´ phosphatase-2 (SHIP2) is as lipid phosphatase which inhibits insulin signaling downstream of phosphoinositide-3-kinase (PI3K); its role in vascular function is poorly understood. To examine its role in endothelial cell (EC) biology, we generated mice with catalytic inactivation of one SHIP2 allele selectively in EC (ECSHIP2Δ/+). Hyperinsulinemic euglycemic clamping studies revealed ECSHIP2Δ/+ were resistant to insulin-stimulated glucose uptake in adipose tissue and skeletal muscle, compared with littermate controls. EC from ECSHIP2Δ/+ had increased basal expression and activation of PI3K downstream targets, including Akt and endothelial nitric oxide synthase (eNOS), although incremental activation by insulin and shear stress was impaired. Insulin-mediated vasodilation was blunted in ECSHIP2Δ/+, as was aortic nitric oxide bioavailability. Acetylcholine-induced vasodilation was also impaired in ECSHIP2Δ/+, which was exaggerated in the presence of a superoxide dismutase/catalase mimetic. Superoxide abundance was elevated in ECSHIP2Δ/+ EC, and was suppressed by PI3K and Nox2 NADPH oxidase inhibitors. These findings were phenocopied in healthy human EC after SHIP2 silencing. Our data suggest that endothelial SHIP2 is required to maintain normal systemic glucose homeostasis and prevent oxidative stress-induced endothelial dysfunction.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Watt, NT
Gage, MC
Patel, PA
Viswambharan, H
Sukumar, P
Galloway, S
Yuldasheva, NY
Imrie, H
Walker, AMN
Griffin, KJ
Makava, N
Skromna, A
Bridge, K
Beech, DJ
Schurmans, Stéphane ; Université de Liège > Département des sciences fonctionnelles (DSF) > Biochimie métabolique vétérinaire
JohnsonAMF, OlefskyJM. The origins and drivers of insulin resistance. Cell2013;152:673–684
2.DuncanER, WalkerSJ, EzzatVA, et al. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab2007;293:E1311–E1319
3.WheatcroftSB, ShahAM, LiJ-M, et al. Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Diabetes2004;53:2645–2652
4.SukumarP, ViswambharanH, ImrieH, et al. Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes2013;62:2130–2134
5.DuncanER, CrosseyPA, WalkerS, et al. Effect of endothelium-specific insulin resistance on endothelial function in vivo. Diabetes2008;57:3307–3314
6.NoronhaBT, LiJM, WheatcroftSB, ShahAM, KearneyMT. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes2005;54:1082–1089
7.LazarDF, SaltielAR. Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat Rev Drug Discov2006;5:333–342
8.KagawaS, SoedaY, IshiharaH, et al. Impact of transgenic overexpression of SH2-containing inositol 5′-phosphatase 2 on glucose metabolism and insulin signaling in mice. Endocrinology2008;149:642–650
9.ClémentS, KrauseU, DesmedtF, et al. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature2001;409:92–97
10.SleemanMW, WortleyKE, LaiK-MV, et al. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat Med2005;11:199–205
11.DuboisE, JacobyM, BlockmansM, et al. Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse. Cell Signal2012;24:1971–1980
12.ViswambharanH, YuldashevaNY, SenguptaA, et al. Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling Loop. Circ Res2017;120:784–798
13.AndersonEJ, LustigME, BoyleKE, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest2009;119:573–581
14.AbbasA, ImrieH, ViswambharanH, et al. The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium. Diabetes2011;60:2169–2178
15.ImrieH, ViswambharanH, SukumarP, et al. Novel role of the IGF-1 receptor in endothelial function and repair: Studies in endothelium-targeted IGF-1 receptor transgenic mice. Diabetes2012;61:2359–2368
16.LiJ, HouB, TumovaS, et al. Piezo1 integration of vascular architecture with physiological force. Nature2014;515:279–282
17.CubbonRM, YuldashevaNY, ViswambharanH, et al. Restoring Akt1 activity in outgrowth endothelial cells from South Asian men rescues vascular reparative potential. Stem Cells2014;32:2714–2723
18.DalmasE, ToubalA, AlzaidF, et al. Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity. Nat Med2015;21:610–618
19.EngelmanJA, LuoJ, CantleyLC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet2006;7:606–619
21.TaniguchiCM, EmanuelliB, KahnCR. Critical nodes in signalling pathways: Insights into insulin action. Nat Rev Mol Cell Biol2006;7:85–96
22.GremplerR, ZibrovaD, SchoelchC, van MarleA, RippmannJF, RedemannN. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis. Diabetes2007;56:2235–2241
23.FukuiK, WadaT, KagawaS, et al. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes2005;54:1958–1967
24.MarionE, KaisakiPJ, PouillonV, et al. The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes2002;51:2012–2017
25.KaisakiPJ, DelépineM, WoonPY, et al. Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes2004;53:1900–1904
26.DuplainH, BurcelinR, SartoriC, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation2001;104:342–345
27.ShankarRR, WuY, ShenHQ, ZhuJS, BaronAD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes2000;49:684–687
28.KubotaT, KubotaN, KumagaiH, et al. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab2011;13:294–307
29.VicentD, IlanyJ, KondoT, et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest2003;111:1373–1380
30.WangC-Y, KimH-H, HiroiY, et al. Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Sci Signal2009;2:ra11
31.KerrBA, MaL, WestXZ, et al. Interference with akt signaling protects against myocardial infarction and death by limiting the consequences of oxidative stress. Sci Signal2013;6:ra67